Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:1879-1887
Published online before print April 10, 2006, doi: 10.1161/CIRCULATIONAHA.106.611731
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
113/15/1879    most recent
CIRCULATIONAHA.106.611731v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matter, C. M.
Right arrow Articles by Lüscher, T. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matter, C. M.
Right arrow Articles by Lüscher, T. F.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
Related Collections
Right arrow Animal models of human disease
Right arrow Apoptosis
Right arrow Genetically altered mice

(Circulation. 2006;113:1879-1887.)
© 2006 American Heart Association, Inc.


Vascular Medicine

Role of Endogenous Fas (CD95/Apo-1) Ligand in Balloon-Induced Apoptosis, Inflammation, and Neointima Formation

Christian M. Matter, MD; Christos E. Chadjichristos, PhD; Patricia Meier; Tobias von Lukowicz, MD; Christine Lohmann; Pia K. Schuler, MD; Dongming Zhang, MD; Bernhard Odermatt, MD; Eugen Hofmann; Thomas Brunner, PhD; Brenda R. Kwak, PhD; Thomas F. Lüscher, MD

From Cardiovascular Research, Institute of Physiology, University of Zurich, and Cardiovascular Center, University Hospital Zurich, Zurich (C.M.M., P.M., T.v.L., C.L., P.K.S., D.Z., T.F.L.); Center for Integrative Human Physiology, University of Zurich, Zurich (C.M.M., P.M., T.v.L., C.L., T.F.L.); Division of Cardiology, University Hospital Geneva, Geneva (C.E.C., B.R.K.); Institute of Clinical Pathology, University Hospital Zurich, Zurich (B.O.); Schneider Europe, Bulach (E.H.); and Division of Immunopathology, Institute of Pathology, University of Bern, Bern (T.B.), Switzerland.

Correspondence to Christian M. Matter, MD, Department of Cardiovascular Research, Institute of Physiology, Zurich University, and Cardiovascular Center, University Hospital Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland. E-mail cmatter{at}physiol.unizh.ch

Received May 6, 2005; de novo received January 2, 2006; accepted February 14, 2006.

Background— Fas (CD95/Apo-1) ligand (FasL)–induced apoptosis in Fas-bearing cells is critically involved in modulating immune reactions and tissue repair. Apoptosis has also been described after mechanical vascular injury such as percutaneous coronary intervention. However, the relevance of cell death in this context of vascular repair remains unknown.

Methods and Results— To determine whether FasL-induced apoptosis is causally related to neointimal lesion formation, we subjected FasL-deficient (generalized lymphoproliferative disorder [gld], C57BL/6J) and corresponding wild-type (WT) mice to carotid balloon distension injury, which induces marked endothelial denudation and medial cell death. FasL expression in WT mice was induced in injured vessels compared with untreated arteries (P<0.05; n=5). Conversely, absence of functional FasL in gld mice decreased medial and intimal apoptosis (terminal deoxynucleotidyltransferase–mediated dUTP nick end labeling [TUNEL] index) at 1 hour and 7 days after balloon injury (P<0.05; n=6). In addition, peritoneal macrophages isolated from gld mice showed no apoptosis and enhanced migration (P<0.05; n=4). In parallel, we observed increased balloon-induced macrophage infiltrations (anti-CD68) in injured arteries of FasL-deficient animals (P<0.05; n=6). Together with enhanced proliferation (bromodeoxyuridine index; P<0.05), these events resulted in a further increase in medial and neointimal cells (P<0.01; n=8) with thickened neointima in gld mice (intima/media ratio, x3.8 of WT; P<0.01).

Conclusions— Our data identify proapoptotic and antiinflammatory effects of endogenous FasL as important factors in the process of neointimal lesion formation after balloon injury. Moreover, they suggest that activation of FasL may decrease neointimal thickening after percutaneous coronary intervention.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
V. Juric, C.-C. Chen, and L. F. Lau
Fas-Mediated Apoptosis Is Regulated by the Extracellular Matrix Protein CCN1 (CYR61) In Vitro and In Vivo
Mol. Cell. Biol., June 15, 2009; 29(12): 3266 - 3279.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. von Lukowicz, P. O. Hassa, C. Lohmann, J. Boren, V. Braunersreuther, F. Mach, B. Odermatt, M. Gersbach, G. G. Camici, B. E. Stahli, et al.
PARP1 is required for adhesion molecule expression in atherogenesis
Cardiovasc Res, April 1, 2008; 78(1): 158 - 166.
[Abstract] [Full Text] [PDF]